About the Observatory

The Parc Taulí Research and Innovation Institute (I3PT) is the result of the integration of excellence in knowledge and innovative capacity and improvement of research groups, integrated in the lines of research and belonging to the institutions constituting the Institute: Parc Taulí Health Corporation, Parc Taulí Foundation, UDIAT Diagnostic Center, Sabadell Elderly Services Center and Autonomous University of Barcelona.

The tradition of years of work together between the five entities, together with the sum of scientific knowledge and research capabilities of all of them, the results achieved in recent years and the uniqueness of the management of innovation in medical technologies, it is the constitution of the I3PT as the next step necessary to strengthen this joint trajectory further and provide better management tools and opportunities to continue improving and growing in R&D results.

The I3PT maintains and enhances research activity in the areas in which they are scientifically excellent, but without losing sight of everything that is transferable to the market, that is, all the potential innovations that will be treated initially as strategic until they are evaluated, regardless of the line or scientific area in which they belong. The excellence is a strategic pillar but also the sustainability. The transferable products in the market must contribute to the sustaining of the Institute's innovation model, either through value and marketing catching business. globally, or through its internal application to the own health activity of the institutions that are part of the Institute.

The research carried out at the Institute meets the criteria of quality, sustainability and excellence.

The I3PT has as mission facilitate and enhance the activity linked to research and innovation, through a sustainable model, which promotes public-private collaboration and that has actions to foster the culture of research and innovation and the development of attraction talent, with working policies and methodologies, and with national and international alliances that allow access to global markets. values guidance to citizens in their diversity, excellence, cooperation and commitment to the environment, as much as with the people and with the environment, the management of the I3PT and its governing bodies from the beginning with the research and the innovation like indispensable elements in the improvement and the quality of the assistance. Research and innovation policy must contribute to the development of lines of research and areas of knowledge and all of their projects, with the main objective of improving health.

Thus, the basic guidelines of the I3PT R&D Policy are specified in:

  • Promote and foster the culture of research and innovation among professionals and establish the activities necessary to achieve this goal annually.
  • Ensure compliance with the relevant regulations and establish and maintain existing regulations; I3PT Code of Best Practices, rules on intellectual and industrial property of research results developed at I3PT, and document on best practices in the field of technology and knowledge transfer.
  • Define, establish and maintain strategic alliances with universities, entities, companies and networks in favor of research development at I3PT.
  • To promote the transfer of knowledge to the scientific community and the market, and to pursue the goals of excellence, value generation and economic return.
  • Have a scorecard that will allow them to be properly monitored in order to achieve their goals and to permanently improve the I3PT's R&D system.
  • Disseminate the R&D Policy between professionals and external agents related to this activity.
  • Work on continuous improvement and put in place all the necessary mechanisms to work with optimum quality.
  • Respect and take care of the environment and keep in mind the aspects related to the planning of its activities.
  • Have the working procedures and structure needed to support research and innovation activities.

The Parc Taulí Research and Innovation Institute (I3PT) has the mission of facilitating and enhancing research and innovation activity through a sustainable model aimed at translating and transferring results, which promotes the generation and attraction of talent, public-private collaboration and state and international alliances, under quality criteria, in response to their values ​​of citizen orientation, excellence, cooperation and commitment to the environment, both with people and with The environment, the Management of the I3PT and its governing bodies have been committed from the beginning with research and innovation as essential elements in the improvement and quality of care. The policy of research and innovation it must contribute to the development of lines of research and areas of knowledge and of all its projects, the main objective of which is the improvement of health.

Thus, the basic guidelines of the I3PT R&D Policy are as follows:

  • Promote and foster a culture of research and innovation among professionals, establishing the appropriate activities annually to achieve this goal.
  • Ensure compliance with the relevant regulations and establish and maintain the existing own regulations: I3PT Code of good practice, Regulations on intellectual and industrial property of the results of the research carried out at l3PT and Document of good practice in technology and knowledge transfer.
  • Define, establish and maintain strategic alliances with universities, entities, companies and networks for the benefit of research development at I3PT.
  • Promote the transfer of knowledge to the scientific community and the market pursuing the goals of excellence, value generation and economic return.
  • Have a table of indicators that allow the proper monitoring in the achievement of objectives and the continuous improvement of the R&D system of the I3PT.
  • Disseminate the R&D Policy between professionals and external agents related to this activity.
  • Working on improvement continues to put in place all the mechanisms needed to work at optimum quality.
  • Respect and take care of the environment, bearing in mind the aspects related to the planning of its activities.
  • Have the working procedures and structure needed to support research and innovation activities.

These guidelines are basic for the preparation of the strategic plan, approved by the governing bodies, from which the research roadmap for the Institute is established, materialized in the objectives established annually, counting on the advice of the Institutional Research and Innovation Committee (CIRI), the Innovation Committee, the Quality Committee and the Scientific Advisory Committee (CAC).

The Parc Taulí Foundation is the managing body of the I3PT, which provides the structure needed to fulfill its purpose.

Approved by the Governing Committee of the I3PT in Sabadell, on June 14, 2017.

Governing Committee

  • Francesc Godia Casablancas - President: representing the Consortium Corporación Sanitària Parc Taulí of Sabadell
  • Modesto Custodio Gómez: representing the Consortium Corporación Sanitària Parc Taulí of Sabadell
  • Joan Martí López: representing the Consortium Corporación Sanitària Parc Taulí of Sabadell
  • Joan Marcet Morera: representing the Consortium Corporación Sanitària Parc Taulí of Sabadell
  • Joan Antoni Gallego Lizana: representing the Consortium Corporación Sanitària Parc Taulí of Sabadell
  • Manel Sabés Shamaní: representing the Autonomous University of Barcelona
  • Lluís Tort Bardolet: representing the Autonomous University of Barcelona
  • Francesc Casas Selvas: representing the Parc Taulí Foundation
  • Joan Tasias Margenat: representing UDIAT Diagnostic Center

Delegate Commission

President

  • Joan Martí López - General Director of the Consortium Corporación Sanitària Parc Taulí of Sabadell

Vice President

  • Francesc Godia Casablancas - President of the Board of Trustees of the Parc Taulí Foundation

Vocals

  • Lluís Blanch Torra - Scientific Director of I3PT
  • Francesc Luque López - Director of Economy and Services of the Parc Taulí Health Consortium of Sabadell
  • Lluís Donoso Bach - Executive Director of UDIAT Diagnostic Center
  • Lluís Tort Bardolet, on behalf of the UAB
  • Cristina Carod Pérez - Executive Director of the Hospital de Sabadell and Albada Social and Health Center

Secretary

  • Gloria Palomar Frias - Director of Management of the I3PT

Scientific Advisory Committee

The Scientific Advisory Committee (CAC) is a consultative and advisory body to the research and innovation activity of Parc Taulí. They are people of recognized national and international prestige in the areas of knowledge that are considered essential for the research and innovation in biomedicine that are developed in the Parc Taulí.

Its members represent various sectors of society, both public and private, in different fields such as research management, intellectual property, science and business.

Functions:

  • Issue opinion and evaluation on the projects that are developed in the Parc Taulí.
  • Identify business opportunities for projects.
  • Identify external business opportunities to propose projects internally.
  • Identify potential partners with whom to establish strategic alliances for the financing, development or marketing of a project and its results.
  • Bring value and legitimacy to the work carried out in R + D + I in the Parc Taulí, in order to increase its efficiency and productivity.

President

  • José Ramón Seoane. Degree in Pharmacy. Graduate in Biochemistry and Molecular Biology and Doctor in Physical Chemistry. Director of the Scientific and Technological Centers, University of Barcelona. He has held various positions and has collaborated with different universities and agencies in Spain to promote biomedical and biotechnological research.

Vocals

  • Joaquín Arenas. Degree in Pharmacy and Doctor of Clinical Biochemistry. Author of more than 200 articles in international magazines, mainly in the field of Neurology and Clinical Genetics, he is currently Scientific Director of the Instituto de Investigación Sanitaria i + 12, of the Hospital October 12 in Madrid, after having he has been, for a few years, director of the Carlos III Health Institute.
  • Julio Arrizabalaga.Doctor in Medicine, specialist in Internal Medicine. Scientific Director of the Biodonostia Research Institute and Research Coordinator of Donostia Hospital. He has been responsible for the CAIBER Research Unit and Principal Investigator of the RETIC de Innovación, of the Donostia Hospital.
  • Enric Barba. Doctor of Telecommunications Engineer. General Manager of the B2B Division of CIRSA, General Manager of UNIDESA and CIRSA INTERACTIVE. Teacher at ESADE Bussines School and the Polytechnic Foundation of Catalonia. He is the author of books on innovation management.
  • Fatima Bosch. Professor of Biochemistry and Molecular Biology at the Autonomous University of Barcelona, ​​where she heads the Center for Animal Biotechnology and Gene Therapy (CBATEG). Among other awards, is the Narcís Monturiol Medal of the Generalitat de Catalunya for scientific and technological merit.
  • Ángel Lanuza. Degree in Industrial Chemical Engineering. Coordinator of the Spanish Technological Technology Innovation Platform of the FENIN, Spanish Federation of Health Technology Companies.
  • Andrés Esteban. Doctor of Medicine, specialist in intensive care. She leads the group 23 of the CIBER of Respiratory Diseases and Professor Emeritus of Research at the University Hospital of Getafe. He has been distinguished with the Gran Cruz de la Sanidad Madrileña, granted by the Community of Madrid.
  • Mª Júlia Prats. Degree in Industrial Engineering. Doctor in Business Administration. Associate Professor at IESE, University of Navarra. She has taught at the Wharton Business School (University of Pennsylvania) and in different business schools in Mexico, Colombia and Portugal.
  • Franscesc Solé Perellada. Degree in Economics and Doctor of Industrial Engineering. Vice President of the Knowledge and Development Foundation. Professor of Business Organization and director of the Research and Innovation Park of the Polytechnic University of Catalonia.